Norwest Venture Partners has invested INR 4.5bn (USD 54m) in Indian hospital operator Regency Healthcare, facilitating an exit for HealthQuad, which generated a 3x return.
Australia’s Five V Capital has confirmed an investment of undisclosed size in Cyclotek, a radioactive drug maker positioning itself as part of an industry transition toward personalized medicine.
Sugarfit, an India-based health technology start-up that helps people manage type-two diabetes with a view to reversing the condition, has raised USD 11m in Series A funding.
US healthcare and life sciences growth investor Polaris Partners has led a USD 27m Series A round for Singapore-based cancer medicine developer Engine Biosciences.
CVC Capital Partners has acquired a 63.94% stake in Philippines-based hospital operator The Medical City (TMC) following the completion of a tender offer.
Healthcare investor OrbiMed has raised USD 4.3bn for its latest set of global funds, including its fifth Asia-focused vehicle.
Specialist healthcare investor CBC Group has reached a second close on its China-focused life science real assets fund with USD 875m in commitments.
East Ventures has launched a dedicated Indonesia healthcare innovation fund with a target of USD 30m.
Singapore-based healthcare specialist Quadria Capital has reached a first close of USD 500m on its third flagship fund. The target is USD 800m.
Singapore’s Quest Ventures has confirmed an investment of undisclosed size in Vietnam-based robotic prosthetics start-up Vulcan Augmetics.
Chinese inflammatory and metabolic disease drug developer Atom Bioscience has raised USD 83m in Series D funding led by local biotech specialist Kaitai Capital.
BPEA EQT has agreed to acquire VetPartners, operator of Australia and New Zealand’s largest network of pet clinics and hospitals, from National Veterinary Associates (NVA).
Mubadala Investment has invested in Osstem Implant, a Korean manufacturer of dental implants that was taken private by MBK Partners and UCK Partners (formerly Unison Capital Korea) earlier this year.
Japan-US cross-border investor World Innovation Lab (WiL) has joined a JPY 4bn (USD 27.3m) Series C round for Tokyo-based telemedicine and health platform Micin.
Impact investor LeapFrog Investments expects to close its fourth flagship fund in February, with a source close to the situation adding that "a significant share" of the targeted USD 1bn has already been raised.
True North has agreed to sell about 20% of its stake in Indian insurance company Niva Bupa to its UK-based joint venture partner, Bupa, for approximately INR 27bn (USD 326m).
L Catterton has led a CNY 200m (USD 27m) Series B round for Trautec, a China-based biotech start-up that develops synthetic proteins used in beauty and healthcare products.
Eastern Bell Capital has led a Series D round of more than CNY 300m (USD 41m) for Huimei Cloud Technology, a China-based provider of artificial intelligence-enabled (AI) software that helps doctors make clinical decisions.
TPG Capital’s Asia Healthcare Holdings has tapped a rich vein for private equity in acquiring India’s only nephrology and urology hospital. Technological leadership will support expansion
Matrix Partners China and HongShan (formerly Sequioa Capital China) have joined a USD 16m pre-Series B round for Qihan Biotech, a genome editing player active in human and agricultural therapies.
The Blackstone Group’s proposed acquisition of India-based hospital chain Care Hospitals from TPG’s The Rise Fund has won approval from the national competition regulator.
China-based drug developer Lynk Pharmaceuticals has closed a second tranche of Series C funding, taking the overall size of the round to CNY 322m (USD 44m).
Asia Healthcare Holdings (AHH), a platform backed by TPG Capital and GIC, has acquired a majority stake in India’s Asian Institute of Nephrology and Urology (AINU) for about USD 72.2m.
Concord Healthcare Group, an onshore subsidiary of US-listed Chinese healthcare business Concord Medical, has filed for an IPO in Hong Kong.